Retroperitoneal fibrosis after chemo-radiotherapy for cervical cancer: A case report.

Abstract

Retroperitoneal fibrosis (RPF) is a rare disease characterized by proliferation of fibro-inflammatory tissue in the retroperitoneum. Multiple studies have reported on the idiopathic cases of the disease, but reports of RPF secondary to irradiation are very limited. Herein, we report the case of a 47-year-old woman who complained of lower abdominal pain 14 months after chemo-radiotherapy for cervical cancer. Computed tomography showed a soft-tissue mass spreading in the presacral space. Biopsy of the lesion revealed fibro-inflammatory tissue without malignancy. Retrospective imaging findings showed that the lesion was consistent with the irradiation field. We diagnosed the patient with RPF caused by radiotherapy. We started oral administration of prednisolone at a dose of 30 mg/day. After 3 months, scans showed a remarkable reduction in lesion size. Prednisolone was tapered to a maintenance dose of 5 mg/day, which is ongoing. The patient is doing well with no recurrence to date.

• Authors: Yuji Takahashi, Hiroshi Matsushima, Taisuke Mori, Tetsuya Kokabu, Fumitake Ito, Jo Kitawaki
• Journal: The journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 45 Issue 4 Pg. 938-941 (Apr 2019) ISSN: 1447-0756 [Electronic] Australia
• PMID: 30788908 (Publication Type: Case Reports)
• Copyright: © 2019 Japan Society of Obstetrics and Gynecology.

Topics

• Female
• Humans
• Middle Aged
• Radiation Injuries (complications)
• Radiotherapy (adverse effects)
• Retroperitoneal Fibrosis (diagnosis, etiology)
• Uterine Cervical Neoplasms (drug therapy, radiotherapy)